ALTRAPHARMA Invest ApS
CVR 34483884 · Private limited company (ApS) · Active · Low risk
ALTRAPHARMA Invest ApS is a Private limited company (ApS), founded on , based in Holte. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 13 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK 104k and a net result of DKK -85k. CEO: Marianne Thrane.
Bankruptcy risk for ALTRAPHARMA Invest ApS
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 34483884
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (14 years)
- Address
- Storkevænget 9
2840 Holte - Municipality
- Rudersdal
- Industry
- Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 80k
- Employees
- 0 (2017)
- Auditor
- Crowe
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 13 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 71.5% |
| Current ratio | 351% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -89k | DKK -42k |
| Net profit | DKK -85k | DKK 87k |
| Equity | DKK 104k | DKK 89k |
| Total assets | DKK 145k | DKK 239k |
| Cash | DKK 61k | – |
| Short-term debt | DKK 41k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Crowe.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 134 | ||
| 1 Jul 2023 – 30 Jun 2024 | 123 | ||
| 1 Jul 2022 – 30 Jun 2023 | 177 | ||
| 1 Jul 2021 – 30 Jun 2022 | 126 | ||
| 1 Jul 2020 – 30 Jun 2021 | 161 | ||
| 1 Jul 2019 – 30 Jun 2020 | 163 | ||
| 1 Jul 2018 – 30 Jun 2019 | 156 | ||
| 1 Jan 2017 – 31 Dec 2017 | 148 | ||
| 1 Jan 2016 – 31 Dec 2016 | 123 | ||
| 1 Jan 2015 – 31 Dec 2015 | 96 | ||
| 1 Jan 2014 – 31 Dec 2014 | 126 | ||
| 1 Jan 2013 – 31 Dec 2013 | 23 | ||
| 18 Apr 2012 – 31 Dec 2012 | 56 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Marianne Thrane | Current | |
| CEO | Gitte Albert | ||
| Owner (67%) | ALTRA 14 ApS | Current | |
| Owner (25%) | Juniwik Business Management AB | Current | |
| Owner (100%) | ALTRAPHARMA HOLDING ApS | ||
| Owner (50%) | ALTRA 14 ApS | ||
| Owner (50%) | ETAG Holding ApS | ||
| Owner (100%) | ALTRA 14 ApS | ||
| Auditor | MJAKP2 I/S | ||
| Auditor | MJAKP P/S | ||
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Auditor | CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB | ||
| Founder | ALTRAPHARMA HOLDING ApS | Current |
The CEOs' other companies
Marianne Thrane – 4 other companies
- ALTRA 14 ApS Active
- ALTRAPHARMA HOLDING ApS Fusioneret
- DBA-ONE ApS Active
- SPLY Holding ApS Active
Gitte Albert – 10 other companies
- ALTRAPHARMA HOLDING ApS Fusioneret
- CN Entertainment Group ApS Opløst
- Celebrity Ninja ApS Opløst
- ETAG Holding ApS Opløst
- GLOBAL HEALTH INVEST APS Active
- Hørlykke Performance Online ApS Active
- SPLY ApS Active
- SPLY Holding ApS Active
- SPLY Tech ApS Fusioneret
- TrialStack ApS Active
Address history (5 moves)
| Storkevænget 9, 2840 Holte | |
| Frydenlundsvej 30, 2950 Vedbæk | |
| c/o Næsseslottet, Dronninggårds Alle 136, 2840 Holte | |
| Ved Næsseskoven 12, 2840 Holte | |
| Havnegade 39, 1058 København K | |
| Parkvej 31, 2791 Dragør |
Former names
| ALTRAPHARMA Invest ApS | – now |
| ALTRAPHARMA ApS | – |
Employees per year
Other companies at the same address
- ALTRA 14 ApS Active
- ORBIT 12 ApS Fusioneret
Similar companies in Rudersdal
- SCANAVIA A/S Vedbæk
- IGH INVEST ApS Vedbæk
- vejarbejde.dk ApS Vedbæk
- Altitec ApS Vedbæk
- Trinomo ApS Skodsborg
- Sensible Energy A/S Birkerød
- Flemming Petroleum Engineering ApS Nærum
- Better Future Ventures ApS Holte
- AI Tech Discover ApS Vedbæk
- EFSEN ICAD Technology A/S Holte
- CETA ApS Vedbæk
- Ascari ApS Nærum
Questions and answers about ALTRAPHARMA Invest ApS
Has ALTRAPHARMA Invest ApS gone bankrupt?
No, ALTRAPHARMA Invest ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ALTRAPHARMA Invest ApS?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of ALTRAPHARMA Invest ApS?
Marianne Thrane is the CEO of ALTRAPHARMA Invest ApS.
Who is the auditor of ALTRAPHARMA Invest ApS?
ALTRAPHARMA Invest ApS most recently used Crowe.
When was ALTRAPHARMA Invest ApS founded?
ALTRAPHARMA Invest ApS was founded on 18 April 2012.
What is the equity of ALTRAPHARMA Invest ApS?
Equity was DKK 104k according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.